These observations underline that the treatment of neuropathic pain is still an unmet medical need. New approaches to the pharmacotherapy of neuropathy embrace different lines of work, including a ...

The heterogeneous nature of the mechanisms underlying neuropathic pain complicates the selection of appropriate treatments for individual patients. Although systematic reviews have outlined the ...

This type of pain can be severe and more difficult to treat. Nerve pain is typically treated with prescription-strength medications, but some over-the-counter products, primarily topical creams ...

Treatment with XG005 resulted in statistically significant and clinically meaningful reduction in post-surgical pain ...

Pacira BioSciences, Inc. (NASDAQ:PCRX) received FDA clearance to market a new Smart Tip designed to access the medial branch ...

For people suffering from chronic knee pain, especially those over 50, a new treatment is offering hope and relief.

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, announced today that it has received clearance ...

Scientists Discover New Receptor for Nerve Growth Factor--a Promising ... About Pain Signaling May Contribute to Better Treatment of Chronic Pain Nov. 18, 2024 — When pain signals are passed ...

However, when the pain persists despite these treatments, it can indicate an underlying issue. Whether stemming from muscle strain, nerve compression, or structural problems in the spine ...

Some of the most commonly-prescribed analgesic medications for dogs include Amantadine, which controls the pain response by antagonizing receptors in the central nervous system, and is used in ...